Brimonidine
Overview
Brimonidine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL844).
API suppliers (5)
Suppliers of Brimonidine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 5 suppliers.
4 of 5 hold a GMP certificate on record in the EU or UK registers
- FDC LimitedIndia1 active DMF GMP on record
- INDOCO REMEDIES LTDIndia1 active DMF GMP on record
- CENTAUR PHARMACEUTICALS PVT LTDIndia1 active DMF GMP on record
- Micro Labs Usa1 active DMF
- MAITHRI DRUGS PRIVATE LTDIndia1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (25 approved US products), the latest listed US patent on Brimonidine expires 13 Jun 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
- Canonical SMILES
- C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
- InChIKey
- XYLJNLCSTIOKRM-UHFFFAOYSA-N
Do you supply Brimonidine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.